Moderna, Alnylam settle patent row over COVID vaccine tech

Moderna (NASDAQ:MRNA) has agreed to resolve a patent litigation in which Alnylam Pharmaceuticals (NASDAQ:ALNY) has alleged that the delivery technology used in the company’s COVID-19 vaccine has violated the latter’s patent rights. According to court filings submitted on Thursday, the duo ...